Results Patient population We included 78,781 patients who had both a prescription for a GLP-1 receptor agonist (GLP-1 RA) and a documented reason for discontinuing the medication between June 2021 and December 2024 (Table 1)
Educational use only This page is an educational research and dosing-context reference, not medical advice or a treatment plan
This can include obtaining internal corporate documents, correspondence with regulators, and clinical trial data that may demonstrate the manufacturers awareness of the serious risks associated with its product and its failure to provide an adequate warning about them
Diabetologia 61 , 284294 (2018)
We will look at treatments for gastroparesis linked to Ozempic, like medical help, diet changes, and other meds for weight and diabetes control
Furthermore, GLP-1Rs have been shown to be able to stimulate the depolarization-evoked release of other neurotransmitters, such as GABA and glutamate, as well as of serotonin and dopamine, in the cortex and hippocampus (Rebosio et al., 2018)